Search Results 381-390 of 10520 for Digoxin toxicity
This medicine is also used in combination with encorafenib to treat non-small cell lung cancer (NSCLC) that has spread in patients who have BRAF V600E mutations ...
Serious skin reactions (eg, Stevens-Johnson syndrome and toxic epidermal necrolysis) can occur with this medicine. Check with your doctor right away if you ...
Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort. J Am Acad Dermatol ...
Swallowed blood, as from a nosebleed or forceful coughing, may cause bloody vomit, but truly vomiting blood usually means something more serious and requires ...
Serious skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS) and toxic epidermal necrolysis can occur with this medicine.
Life threatening or fulminant CDI with evidence of hypotension, septic shock, peritoneal signs or absence of bowel sounds, or toxic megacolon. Current ...
Other signs of an overdose are severe nausea and vomiting, increasing muscle weakness, greatly increased sweating, and greatly increased watering of the mouth.
There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...
Description. Naxitamab-gqgk injection is used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat relapsed (has come ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.